Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Chuck Moore's thoughts on the settlement

Thanks, Laurie, for the link.

In the big picture, I feel Chuck has lost a lot more than any individual PTSC shareholder. In his Nov 15th blog he said Leckrone TPL failed to make a promised payment on a $2M land mortgage and so his property would be foreclosed upon, at a potential loss of $5M. Not sure how it turned out for him but I get the impression he lost the property and the house on it.

A new PTSC BOD could try to mend fences with Chuck but if I read it correctly it is TPL and not he that owns the other 50% of MMP licensing rights. Chuck is dependent on a monetary agreement whereby he receives a percentage of TPL's gross/net/adjusted revenues.

Other than "United we stand against Leckrone" what mutual benefit could be had by PTSC and Chuck working together in a trustworthy relationship?

Share
New Message
Please login to post a reply